Home Compounds isolated from hexane fraction of Alternanthera brasiliensis show synergistic activity against methicillin resistant Staphylococcus aureus
Article
Licensed
Unlicensed Requires Authentication

Compounds isolated from hexane fraction of Alternanthera brasiliensis show synergistic activity against methicillin resistant Staphylococcus aureus

  • Enitan Omobolanle Adesanya ORCID logo EMAIL logo , Mubo Adeola Sonibare , Edith Oriabure Ajaiyeoba and Samuel Ayodele Egieyeh
Published/Copyright: July 1, 2021
Become an author with De Gruyter Brill

Abstract

Methicillin resistant Staphylococcus aureus (MRSA) has been classified as a “serious threat” by the centre for Disease Control, USA. Alternanthera brasiliensis plant, usually found on wasteland, belongs to the family Amaranthaceae. It is traditionally used for wound healing and has shown antimicrobial effect. Yet, this plant has not been fully explored for its antibacterial activity. Hence, this study evaluated isolated compounds from this plant for its activity against MRSA infections. The leaves extracts and fractions were prepared and concentrated in vacuo using a rotatory evaporator. Isolated compounds were obtained through vacuum liquid chromatographic (VLC) techniques and structurally elucidated with various spectroscopic techniques. Anti-MRSA assay of the fraction and compounds were evaluated by agar-well diffusion and broth-dilution methods while checkerboard assay was used to determine the fractional inhibitory concentration index (FICi). The Gas Chromatography-Mass Spectrometry (GCMS) and High Performance Liquid Chromatography (HPLC) analysis revealed fatty acid and carboxylic acid components like hexadecanoic acid, bis (2-ethylhexyl) phthalate and Fettsäure. The compounds AbHD1 and AbHD5 were identified as hexadecanoic acid and di (ethylhexyl) phthalate. Anti-MRSA assay shows that A. brasiliensis hexane fraction (AbHF) and the compounds had zones of inhibitions (Zi) ranging from 7.3 ± 0.5 to 17.5 ± 0.5 mm with minimum inhibitory concentrations (MIC) between 1.22 × 10−5 – 2.5 mg/mL. Synergistic effects were observed between AbHF and erythromycin, AbHF and ampicillin and AbHF and ciprofloxacin with FICi 0.208–0.375 in K1St4 strain while amoxicillin revealed antagonistic effects against M91 strain (4.67). Similarly, hexadecanoic acid and di (ethylhexyl) phthalate showed synergistic behaviour only with ampicillin against K1St4 while the rest were antagonistic. The study revealed that hexadecanoic acid and di (ethylhexyl) phthalate isolated from A. brasiliensis showed synergistic activity in variations against MRSA isolate and strains.


Corresponding author: Enitan Omobolanle Adesanya, Department of Pharmacognosy, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

Appendix
Tabe A1:

Compounds identified from Alternanthera brasiliensis hexane fraction via GCMS analysis.

S/no Retention Time (min) Compound name
1 5.82 Ar-tumerone
2 Phenyl tiglate, 2-(1Z)-propenyl-
3 Tumerone
4 (Z)-.gamma.-Atlantone
5 (E)-.gamma.-Atlantone
6 4.40 Curlone
7 2-Methyl-6-(4-methylenecyclohex-2-en-1-yl)hept-2-en-4-one
8 Benzoic acid, 4-amino-, 4-acetoxy- 2,2,6,6-tetramethyl-1-piperidinyl ester
9 4.71 2-Pentadecanone, 6,10,14-trimethyl
10 2-Undecanone, 6,10-dimethyl-
11 7.09 Neophytadiene
12 Bicyclo[3.1.1]heptane, 2,6,6-trimethyl-
13 Bicyclo [3.1.1] heptane, 2, 6, 6-trimethyl-, (1.alpha. 2. beta., 5.alpha.)
14 1.69 3,7,11,15-Tetramethyl-2-hexadecen-1-ol
15 1,4-Eicosadiene
16 2.89 9-Eicosyne
17 1-Hexadecyne
18 5.93 Hexadecanoic acid, methyl ester
19 17.06 n-Hexadecanoic acid
20 1.84 Methyl 10-trans,12-cis-octadecadienoate
21 9,12-Octadecadienoic acid, methyl ester
22 1.90 11-Octadecenoic acid, methyl ester
23 9-Octadecenoic acid, methyl ester, (E)-
24 9-Octadecenoic acid (Z)-, methyl ester
25 22.34 Phytol
26 1.59 Methyl stearate
27 Heptadecanoic acid, 16-methyl-, methyl ester
28 2.34 2-Methyl-Z,Z-3,13-octadecadienol
29 Cyanoacetylurea
30 1,19-Eicosadiene
31 2.05 4,8,12,16-Tetramethylheptadecan-4-olide
32 2(3H)-Furanone, 5-butyldihydro-4-methyl-
33 5.59 Bis(2-ethylhexyl) phthalate
34 Phthalic acid, di(2-propylpentyl)ester
35 6.69 Squalene
36 Supraene
37 1.40 Cyclotrisiloxane, hexamethyl-
38 Benzo[h]quinoline, 2,4-dimethyl-
39 1-methyl-4-phenyl-5-thioxo-1,2,4-triazolidin-3-one
40 Tetrasiloxane, decamethyl-
Table A2:

HPLC analysis of A. brasiliensis hexane fraction.

S/no Likely component expected
1 Cyclo(polylvaly 1)
2 Cerebroside
3 9-OH-pinoresinol
4 Aureonitol
5 Fetts äure
6 Bastadin 2
7 Herbarin B
8 Indo-3-Carbaldehyde
9 Aloresin A
10 2,3-Dibromoaldsin
11 Septone
12 (E,Z) Paucin
13 (Z)-oct.2-ene 1,3,8-tricarboxylic acid
Table A3:

HSQC assignment of AbHD1.

Position 13C NMR

Experimental
13C NMR

Reporteda
1H NMR

Experimental
1H NMR

Reporteda
Type of Carbon
1 178.7 178.7 C
2 34.1 34.1 2.33 (2H, t, J = 8.0 Hz) 2.33 (2H, t, J = 8.0 Hz) CH2
3 24.9 24.9 1.23–1.40 (2H, m) 1.61 (2H, m) CH2
4 29.1 29.9–29.3 1.23–1.40 (2H, m) 1.28 (2H, m) CH2
5 29.4 29.9–29.3 1.23–1.40 (2H, m) 1.28 (2H, m) CH2
6 29.7 29.9–29.3 1.23–1.40 (2H, m) 1.28 (2H, m) CH2
7 29.7 29.9–29.3 1.23–1.40 (2H, m) 1.28 (2H, m) CH2
8 29.7 29.9–29.3 1.23–1.40 (2H, m) 1.28 (2H, m) CH2
9 29.7 29.9–29.3 1.23–1.40 (2H, m) 1.28 (2H, m) CH2
10 29.7 29.9–29.3 1.23–1.40 (2H, m) 1.28 (2H, m) CH2
11 29.7 29.9–29.3 1.23–1.40 (2H, m) 1.28 (2H, m) CH2
12 29.7 29.9–29.3 1.23–1.40 (2H, m) 1.28 (2H, m) CH2
13 29.4 29.9–29.3 1.23–1.40 (2H, m) 1.28 (2H, m) CH2
14 31.9 32.1 1.23–1.40 (2H, m) 1.28 (2H, m) CH2
15 22.7 22.9 1.23–1.40 (2H, m) 1.28 (2H, m) CH2
16 14.1 14.2 0.86 (3H, t, J = 8.0 Hz) 0.86 (3H, t, J = 8.0 Hz) CH3
  1. m, multiplet; t, triplet; J = coupling constant in Hertz. aReported by Fadzil et al. [14].

Table A4:

HSQC assignment of compound ABHD5 [di(2-ethylhexyl) phthalate].

Position 1H NMR 13C NMR (Observed) 13C NMR (aReported)
1 7.62 (1H, dd, J = 5.6, 3.3 Hz) 128.8, CH 129.1, CH
2 7.45 (1H, dd, J = 5.6, 3.3 Hz) 130.9, CH 131.2, CH
3 7.45 (1H, dd, J = 5.7, 3.3 Hz) 130.9, CH 131.2, CH
4 7.62 (1H, dd, J = 5.7, 3.3 Hz) 128.8, CH 129.1, CH
1′ 132.5,qC 132.8, qC
2′ 167.8, qC 168.1, qC
3′ 4.20 (2H, dd, J = 10.9, 5.8 Hz) 68.2, CH2 68.5, CH2
4′ 2.15 (1H, m) 39.4, CH 39.1, CH
5′ 1.10–1.90 (2H, m) 30.4, CH2 30.7, CH2
6′ 1.10–1.90 (2H, m) 29.4, CH2 29.3, CH2
7′ 1.10–1.90 (2H, m) 23.8, CH2 23.3, CH2
8′ 0.80–0.90 (3H, t, J = 6.8 Hz) 14.1, CH3 14.4, CH3
9′ 1.10–1.90 (2H, m) 24.8, CH2 24.1, CH2
10′ 0.80–0.90 (3H, t, J = 6.8 Hz) 10.9, CH3 11.3, CH3
1″ 132.5,qC 132.8, qC
2″ 167.8,qC 168.1, qC
3″ 4.20 (2H, dd, J = 10.9, 5.8 Hz) 68.2, CH2 68.5, CH2
4″ 2.15 (1H, m) 39.4,CH 39.1, CH
5″ 1.10–1.90 (2H, m) 30.4, CH2 30.7, CH2
6″ 1.10–1.90 (2H, m) 29.4, CH2 29.3, CH2
7″ 1.10–1.90 (2H, m) 23.8, CH2 23.3, CH2
8″ 0.80–0.90 (3H, t, J = 6.8 Hz) 14.1, CH3 14.4, CH3
9″ 1.10–1.90 (2H, m) 24.8, CH2 24.1, CH2
10″ 0.80–0.90 (3H, t, J = 6.8 Hz) 10.9, CH3 11.3, CH3
  1. aReported by Nair et al. [15]. qC, quaternary carbon; dd, double doublet; m, multiplet; t, triplet.

Figure A1: 

1H NMR spectrum of AbHD1.
Figure A1:

1H NMR spectrum of AbHD1.

Figure A2: 
Proton NMR of AbHD5.
Figure A2:

Proton NMR of AbHD5.

Figure A3: 
Carbon – 13 NMR of AbHD1.
Figure A3:

Carbon – 13 NMR of AbHD1.

Figure A4: 
Carbon 13 of AbHD5.
Figure A4:

Carbon 13 of AbHD5.

Figure A5: 
NOESY of AbHD1.
Figure A5:

NOESY of AbHD1.

Figure A6: 
NOESY of AbHD5.
Figure A6:

NOESY of AbHD5.

Figure A7: 
HMQC of AbHD1.
Figure A7:

HMQC of AbHD1.

Figure A8: 
HMQC of AbHD5.
Figure A8:

HMQC of AbHD5.

Figure A9: 
Proton NMR of AbHD5.
Figure A9:

Proton NMR of AbHD5.

Figure A10: 
Carbon 13 of AbHD5.
Figure A10:

Carbon 13 of AbHD5.

Figure A11: 
NOESY of AbHD5.
Figure A11:

NOESY of AbHD5.

Figure A12: 
HMQC of AbHD5.
Figure A12:

HMQC of AbHD5.

References

1. Nichols, H. All you need to know about MRSA. In: Newsletter January edition MedicalNewsToday. Brighton, UK: Healthline Media; 2020.Search in Google Scholar

2. Ramirez-Rueda, R. Natural plant products used against methicillin-resistant Staphylococcus aureus. In: Fighting multidrug resistance with herbal extracts, essential oils and their components (p. 240) Chapter 2: Natural agents from plants used against methicillin-resistant Staphylococcus aureus. Netherlands: Elsevier; 2013.10.1016/B978-0-12-398539-2.00002-1Search in Google Scholar

3. World Health Organisation. WHO publishes list of bacteria for which new antibiotics are urgently Needed. Geneva: World Health Organisation; 2017.Search in Google Scholar

4. Azman, N, Hassan, M, Nissapatorn, V, Uthaipibull, C. Anti-infective activities of 11 plants species used in traditional medicine in Malaysia. Exp Parasitol 2018;194:67–78.10.1016/j.exppara.2018.09.020Search in Google Scholar

5. Sánchez-Del, P, Motley, T, Borsch, T. Molecular phylogenetics of Alternanthera (Gomphrenoideae, Amaranthaceae): resolving a complex taxonomic history caused by different interpretations of morphological characters in a lineage with C. Bot J Linn Soc 2012;169:493–517.10.1111/j.1095-8339.2012.01248.xSearch in Google Scholar

6. Tanveer, A, Khaliq, A. A review on genus Alternanthera weeds implications. Pakistan. J Weed Sci Res 2013;19:53–8.Search in Google Scholar

7. Burkill, H. The useful plants of west tropical Africa. Kew: Royal Botanic Gardens; 2004.Search in Google Scholar

8. Taib, C, Rai, M, Kon, K, Mat, N, Farahziela, A, Mohd, M, et al.. Antioxidant Properties of Crude Extract, Partition Extract, and Fermented Medium of Dendrobium sabin Flower. Evid base Compl Alternative Med 2017;2017:1–9. 2907219.10.1155/2017/2907219Search in Google Scholar

9. Isah, Y, Ndukwe, I, Ayo, R, Yakubu, R. Vacuum liquid chromatographic isolation and characterization of beta-sitosterol from the bark of Sarcocephalus latifolius (Smith Bruce). J Chem Chem Sci 2015;5:480–8.Search in Google Scholar

10. Clinical Laboratory Standards Institute (formerly NCCLS) – Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 18th informational supplement M100-S18. Wayne, PA: CLSI; 2016.Search in Google Scholar

11. Mirtaghi, S, Torbati Nejad, P, Mazandarani, M, Livani, F, Bagheri, H. Evaluation of antibacterial activity of Urtica dioica L. leaf ethanolic extract using agar well diffusion and disc diffusion methods. Med Lab J 2016;10:15–21. https://doi.org/10.18869/acadpub.mlj.10.5.15.Search in Google Scholar

12. Olajuyigbe, O. Synergistic influence of tetracycline on the antibacteria activities of amoxicilin against resistant bacteria. J Pharm Allied Health Sci 2012;2:12–20. https://doi.org/10.3923/jpahs.2012.12.20.Search in Google Scholar

13. Renk-ngam, N, Chimnoi, N, Khunnawutmanotham, N, Techasakul, S. Antimicrobial activity of coronarin D and its synergistic potential with antibiotics. BioMed Res Int 2014;10:1155. https://doi.org/10.1155/2014/581985.Search in Google Scholar PubMed PubMed Central

14. Fadzil, SR, Yap, A, Choo, Y. A new cyclopentylidene and other chemical constituents from Malaysian Crotalaria pallida (Siklopentilidena Baru dan Juzuk Kimia Lain daripada Crotalaria pallida Malaysia). Sains Malays 2017;46:1581–6. https://doi.org/10.17576/jsm-2017-4609-29.Search in Google Scholar

15. Nair, JJ, Ndhlala, AR, Chukwujekwu, JC, Van Staden, J. Isolation of di (2-ethylhexyl) phthalate from a commercial South African cognate herbal mixture. South Afr J Bot 2012;80:21–4. https://doi.org/10.1016/j.sajb.2012.01.008.Search in Google Scholar

16. Matias, E, Santos, K, Almeida, T, Costa, J, Coutinho, H. Enhancement of antibiotic activity by Cordia verbenacea DC. Acta Farm Bonaerense 2010;29:1049–52.Search in Google Scholar

17. Al‐Majmaie, S, Nahar, L, Rahman, M, Nath, S, Saha, P, Talukdar, A, et al.. Anti‐MRSA constituents from Ruta chalepensis (rutaceae) grown in Iraq, and in silico studies on two most active compounds, chalepensin and 6‐hydroxy‐rutin 3’, 7‐dimethyl ether. Molecules 2021;26:1114.10.3390/molecules26041114Search in Google Scholar

18. Song, R, Yu, B, Friedrich, D, Li, J, Shen, H, Krautscheid, H, et al.. Naphthoquinone-derivative as a synthetic compound to overcome the antibiotic resistance of methicillin-resistant S. aureus. Commun Biol 2020;3:529. https://doi.org/10.1038/s42003-020-01261-0.Search in Google Scholar PubMed PubMed Central

19. Carmona, F, Pereira, A. Herbal medicines: old and new concepts, truths and misunderstandings. Rev Bras Farmacogn 2013;23:379–85. https://doi.org/10.1590/s0102-695x2013005000018.Search in Google Scholar

20. Matias, E, Souza, C, Tintino, S, Guedes, G, Medeiro, C, Flaviana, M, et al.. Screening the in vitro modulation of antibiotic activity of the extracts and fractions of Ocimum gratissimum L. Afr J Microbiol Res 2012;6:1902–7.10.5897/AJMR11.652Search in Google Scholar

21. Kali, A. Antibiotics and bioactive natural products in treatment of methicillin resistant Staphylococcus aureus: a brief review. Phcog Rev 2015;9:29–34. https://doi.org/10.4103/0973-7847.156329.Search in Google Scholar PubMed PubMed Central

22. Haq, A, Siddiqi, M, Batool, S, Islam, A, Khan, A, Khan, S, et al.. Comprehensive investigation on the synergistic antibacterial activities of Jatropha curcas pressed cake and seed oil in combination with antibiotics. Amb Express 2019;9:67–88. https://doi.org/10.1186/s13568-019-0793-6.Search in Google Scholar PubMed PubMed Central

23. Nagendra Prasad, H, Karthik, C, Manukumar, H, Mailesha, L, Mailu, P. New approach to address antibiotic resistance: miss loading of functional membrane microdomains (FMM) of methicillin-resistant Staphylococcus aureus (MRSA). Microb Pathog 2019;127:106–15. https://doi.org/10.1016/j.micpath.2018.11.038.Search in Google Scholar PubMed

24. Okwu, M, Olley, M, Akpoka, A, Izevbuwa, O. Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: a brief review. AIMS Microbiol 2019;5:117–37. https://doi.org/10.3934/microbiol.2019.2.117.Search in Google Scholar PubMed PubMed Central

25. Yang, Y, Song, H, Choi, T, Bhatia, S, Lee, S, Park, S, et al.. Combination therapy using low-concentration oxacillin with palmitic acid and Span85 to control clinical methicillin-resistant Staphylococcus aureus. Antibiotics 2020;9:681–92. https://doi.org/10.3390/antibiotics9100682.Search in Google Scholar PubMed PubMed Central

26. Kim, S, Park, M. Phthalate exposure and childhood obesity. Annu Pediatr Endocrinol Metabol 2014;19:69–75. https://doi.org/10.6065/apem.2014.19.2.69.Search in Google Scholar PubMed PubMed Central

27. Lee, L, Kemung, H, Tan, L, Khan, T, Chan, K, Pusparajah, P, et al.. Streptomyces as a prominent resource of future anti-MRSA drugs. Front Microbiol 2018;10:1–15.10.3389/fmicb.2018.02221Search in Google Scholar

28. Driche, E, Belghit, S, Zitouni, A, Sabaou, N, Badji, B, Bijani, C, et al.. A new Streptomyces strain isolated from Saharan soil produces di-(2-ethylhexyl) phthalate, a metabolite active against methicillin-resistant Staphylococcus aureus. Annu Microbiol 2015;65:1341–50. https://doi.org/10.1007/s13213-014-0972-2.Search in Google Scholar

29. Gonzales, P, Pesesky, M, Bouley, R, Ballard, A, Biddy, B, Suckow, M, et al.. Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA. Nat Chem Biol 2015;11:855–61. https://doi.org/10.1038/nchembio.1911.Search in Google Scholar PubMed PubMed Central

30. Tyers, M, Wright, G. Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat Rev Microbiol 2019;17:141–55. https://doi.org/10.1038/s41579-018-0141-x.Search in Google Scholar PubMed

31. Ng’uni, T, Mothlalamme, T, Daniels, R, Klaasen, J, Fielding, B. Additive antibacterial activity of naringenin and antibiotic combinations against multidrug resistant Staphylococcus aureus. Afr J Microbiol Res 2015;9:1513–18.10.5897/AJMR2015.7514Search in Google Scholar

Published Online: 2021-07-01

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Influence of lime (CaO) on low temperature leaching of some types of bauxite from Guinea
  4. Ethnobotanical survey, phytoconstituents and antibacterial investigation of Rapanea melanophloeos (L.) Mez. bark, fruit and leaf extracts
  5. Catalytic properties of supramolecular polymetallated porphyrins
  6. Lignin-based polymers
  7. Bio-based polyhydroxyalkanoates blends and composites
  8. Biodegradable poly(butylene adipate-co-terephthalate) (PBAT)
  9. Repurposing tires – alternate energy source?
  10. Theoretical investigation of the stability, reactivity, and the interaction of methyl-substituted peridinium-based ionic liquids
  11. Polymeric membranes for biomedical applications
  12. Design of locally sourced activated charcoal filter from maize cob for wastewater decontamination: an approach to fight waste with waste
  13. Synthesis of biologically active heterocyclic compounds from allenic and acetylenic nitriles and related compounds
  14. Magnetic measurement methods to probe nanoparticle–matrix interactions
  15. Health and exposure risk assessment of heavy metals in rainwater samples from selected locations in Rivers State, Nigeria
  16. Evaluation of raw, treated and effluent water quality from selected water treatment plants: a case study of Lagos Water Corporation
  17. A chemoinformatic analysis of atoms, scaffolds and functional groups in natural products
  18. Hemicyanine dyes
  19. Thermodynamics of the micellization of quaternary based cationic surfactants in triethanolamine-water media: a conductometry study
  20. Compounds isolated from hexane fraction of Alternanthera brasiliensis show synergistic activity against methicillin resistant Staphylococcus aureus
  21. Internal structures and mechanical properties of magnetic gels and suspensions
  22. SPIONs and magnetic hybrid materials: Synthesis, toxicology and biomedical applications
  23. Magnetic field controlled behavior of magnetic gels studied using particle-based simulations
  24. The microstructure of magnetorheological materials characterized by means of computed X-ray microtomography
  25. Core-modified porphyrins: novel building blocks in chemistry
  26. Anticancer potential of indole derivatives: an update
  27. Novel drug design and bioinformatics: an introduction
  28. Multi-objective optimization of CCUS supply chains for European countries with higher carbon dioxide emissions
  29. Exergy analysis of an atmospheric residue desulphurization hydrotreating process for a crude oil refinery
  30. Development in nanomembrane-based filtration of emerging contaminants
  31. Supply chain optimization framework for CO2 capture, utilization, and storage in Germany
  32. Naturally occurring heterocyclic anticancer compounds
  33. Part-II- in silico drug design: application and success
  34. Advances in biopolymer composites and biomaterials for the removal of emerging contaminants
  35. Nanobiocatalysts and photocatalyst in dye degradation
  36. 3D tumor model – a platform for anticancer drug development
  37. Hydrogen production via water splitting over graphitic carbon nitride (g-C3N4 )-based photocatalysis
Downloaded on 13.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/psr-2020-0113/html
Scroll to top button